Want to join the conversation?
$STJ said it received U.S. Food and Drug Administration (FDA) approval of the company's proprietary MultiPoint Pacing technology. The company also announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac resynchronization therapy defibrillator.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th